Qbrelis
- Product NDC
- 52652-3001
- 11-digit product format
- 526523001
- Labeler code
- 52652
- Product ID
- 52652-3001_461e97d5-c8b3-75a7-e063-6394a90a6ec6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- lisinopril
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- Azurity Pharmaceuticals, Inc.
- Application
- NDA208401
- Marketing category
- NDA
- Marketing start
- 2016-08-29
- Substance
- LISINOPRIL
- Active strength
- 1 mg/mL
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Qbrelis
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| LISINOPRIL | 1 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | E7199S1YWR |
| Rxcui | 1806884, 1806890 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 52652-3001-1 | Qbrelis | 150 mL in 1 BOTTLE | SOLUTION | 150 | | 10 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 52652-3001 | QBRELIS (LISINOPRIL) SOLUTION [AZURITY PHARMACEUTICALS, INC.] | 9 | Current NDC, Legacy NDC, 1 package rows | 20240724_9f6e4e57-a489-4b36-b093-b93865d3717c.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 52652-3001-1 | 52652300101 | 150 mL in 1 BOTTLE (52652-3001-1) | 150 ml | 2016-08-29 | 0000-00-00 | No | No | Current |